New Key Statistics Module, Z-Score and F-Score
NAS:CUE Key Ratios
| Market Cap $ M | 75.40 |
| Enterprise Value $ M | 52.23 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 2.67 |
| Price/Sales | 11.00 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 7.00 |
| EPS (TTM) $ | -1.07 |
| Beneish M-Score | 9.81 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 10.00 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.07 |
| EV-to-EBITDA | -1.15 |
| PEG | -- |
| Shares Outstanding M | 48.64 |
| Net Margin (%) | -711.84 |
| Operating Margin % | -730.47 |
| Pre-tax Margin (%) | -711.84 |
| Quick Ratio | 2.47 |
| Current Ratio | 2.47 |
| ROA % (ttm) | -73.66 |
| ROE % (ttm) | -118.52 |
| ROIC % (ttm) | -237.61 |
| Dividend Yield % | -- |
| Altman Z-Score | -8.38 |
CUE Number of Guru Trades
CUE Volume of Guru Trades
Gurus Latest Trades with NAS:CUE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CUE is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Cue Biopharma Inc Insider Transactions
No Available Data
News about NAS:CUE
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers